Doctor Ping-Chun Li specializes in complicated adult vascular procedures, coronary artery bypass graft, Main artery procedure and support, congenital heart disease procedures, mechanical arm assisted heart surgery and heart transplant. Non pulse coronary artery bypass graft has become the Hospital’s standard operation method. It reduces the patient’s pain and speed up the recovery process as well as the number of days in the hospital’s administration.

Renal transplantation Dialysis Chronic kidney disease

Director Chao-Hsiang Chang completed his Urology Specialist training at Taichung Veterans General Hospital and was an attending physician there. He went to Ann Arbor Medical Center, University of Michigan for advanced training. In 1995, he took the position of Director of Department of Urology, Dali Rengai Hospital, and has been working at the Hospital since 2001. He specializes in complication in urinating, and minimally invasive urological procedures (laparoscope and Da Vinci Procedure System), including urinary incontinence and Neurogenic Bladder, bladder prolapse, swelling of prostatomegaly, renal cancer, epidermal cancer, bladder cancer, prostate cancer, director and vice president of Taiwan Urological Association (Central region)

Clinical Data Research
Biostatistics
Epidemiologic Methods
Environmental Sciences
Clinical Medicine and Nephrology

Dr. Ping-Chin Lai specializes in the diagnosis and treatment of kidney diseases; including kidney transplantation, acute and chronic kidney disease, hemodialysis, peritoneal dialysis, hypertension, and diabetes. Dean Lai has extensive experience in kidney transplantation and is good at other kidney-related diseases. Kidney disease usually manifests in hematuria, proteinuria, electrolyte abnormalities, edema, and accompanying hypertension; patients with chronic renal failure (referred to as chronic renal failure) must be considered for hemodialysis, peritoneal dialysis, or kidney transplantation.

Professor Jin-Jer Chen is a cardiovascular disease expert who specializes in the diagnosis and treatment of general medical diseases, cardiovascular diseases, arrhythmia and hypertension, as well as cardiac ultrasound and cardiac catheterization. He was previously a professor of internal medicine at National Taiwan University Hospital, a researcher at the Institute of Biomedicine, Academia Sinica, a consultant cardiologist at the King's Hospital of Jeddah and King of Saudi Arabia in Saudi Arabia and a visiting professor of cardiology at the University of Toronto, Canada. Dr. Chen has conducted in-depth studies on molecular mechanisms of cardiovascular disease and molecular biology including cardiac hypertrophy, heart failure, arteriosclerosis and hypertension and published over 150 articles in internationally renowned journals.

Dr. Zhou Xiangtai is a medical doctor from Japan's National Kobe University. He used to be a physician of cardiology of Taipei Veterans General Hospital and a fellow of cardiology of the University of California, San Francisco. Awarded the American College of Cardiology. Chow's specialty is in medical treatment of cardiovascular disease, especially hypertension and heart failure, as well as various cardiac imaging diagnostics such as echocardiography and 640-cut computed tomography coronary angiography. Dr. Zhou's research focuses on Cardiac Ultrasound, Cardiology, Molecular Cardiology and Cardiomyopathies.

Dr. Joung-Liang Lan, is a specialist of Allergy, Immunology, and Rheumatology. He served as Visiting Scholar of Johns Hopkins Center, USA. He earned as the Master Award from Taiwan College of Rheumatology (TCR, 2013) and Asia-Pacific League of Associations of Rheumatology (APLAR, 2017). Currently, he serves as an advisor to the Dean’s office of CMUH and Distinguished Professor of China Medical Univ. He served as President of TCR (2009-2011). His research interests include pathogenesis of autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and connective tissue diseases associated with interstitial lung disease (CTD-ILD). The laboratory focuses on identifying the novel biomarkers and autoantibodies for diagnosing autoimmune disease and monitoring progression of CTD-ILD. He is the principal investigator of more than fifty international clinical trials (phase I-III,1995-2024).

Dr. Der-Yuan Chen, is a specialist of Allergy, Immunology, Rheumatology. He earned as an excellent Dr. of CMUH (2022), the Master Award from Taiwan College of Rheumatology (TCR) (2023) and Asia-Pacific League of Associations of Rheumatology (APLAR) (2024). He serves as the director/vice superintendent of Rheumatology/Immunology Center of CMUH. He served as President of TCR (2014-2016). His research interests include immunopathogenesis of autoimmune diseases (SLE, RA) and autoinflammatory disease (AOSD), an association of infection with immune-mediated inflammatory diseases, and the safety profile of biological/targeted synthetic DMARDs. With an excellent achievement in SLE research, he has won the SLE Academic Research Award from the Society of Immunology and participated in the development of APLAR guidelines for SLE treatment (Lancet Rheumatology 2022). He has thirty-five AOSD-related papers published in SCI journals, including Ann Rheum Dis and Arthritis Rheumatol, and also by Kelly's textbooks of Rheumatology. He has been awarded an outstanding researcher by various organizations. With 265 peer-reviewed publications in SCI Journals (~2025.01), He was listed as one of the World’s Top 2% Scientists in 2020-2024 [Citation: 11,100, H-index: 55 and i10-index: 209 (Google Scholar, 2025.01)]

Spinal surgery Minimal invasive surgery Brain tumor